3% Diquafosol Ophthalmic Solution for Active Moderate-to-Severe Vernal Keratoconjunctivitis
3% Diquafosol Ophthalmic Solution for Active Moderate-to-Severe Vernal Keratoconjunctivitis
Recruiting · NCT06903884 · Registry updated 2026-04-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| 3% Diquafosol Ophthalmic Solution for Active Moderate-to-Severe Vernal Keratoconjunctivitis | Conjunctival Diseases, Conjunctivitis, Allergic, Hypersensitivity, Immediate, conjunctivitis, dry eye syndrome, eye disorder, immune system disorder, lacrimal apparatus disorder | Recruiting | Phase 3 | 2026-04-30 | NCT06903884 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| The University of Hong Kong | 349 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| HKU Eye Centre | Hong Kong | Hong Kong | 2 |